Nasal cavity is becoming one of the most potential and promising route of drug delivery, owing to its advantages such as bypassing the hepatic first-pass metabolism, and most importantly patient convenience. The report provides in depth understanding of developing intranasal formulation to achieve better therapeutic objective, in turn drive the market share. However, the report also focuses on the practical and technical factors which remains the hindrance for the global nasal drug delivery system market growth over the forecast period. Furthermore, report tracks and forecast the market growth of each segment for the period of 2016-2026.
Market Dynamics
The major factors driving growth of the nasal drug delivery systems market includes, increasing product launches coupled with technologically advanced drug delivery systems and increasing incidence of nasal cavity associated diseases. For instance, in June 2018, Insys Therapeutics, Inc., a specialty pharmaceutical company, conducted clinical trial for epinephrine nasal spray, an alternative for intramuscular injection for the indication of anaphylaxis. Furthermore, companies have large number of pipeline drugs, which are to be delivered intranasally such as Acerus Pharmaceuticals Corporation is investigating TEFINA, a testosterone nasal gel, for addressing the unmet treatment demand for female sexual dysfunction. However, intranasal route of drug delivery is not suitable for all drug types, which is expected to be a major restrain for growth of the nasal drug delivery systems market.
Key features of the study:
This report provides in-depth analysis of the nasal drug delivery systems market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2017 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global nasal drug delivery systems market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
Key companies covered as a part of this study include Merck & Co., GlaxoSmithKline plc, AstraZeneca plc, Johnson & Johnson, Pfizer Inc., Baxter International, Inc., Valeant Pharmaceuticals International, Inc., Becton, Dickinson and Company and Novartis AG
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, distribution channel upgrades, market expansion and marketing tactics.
The global nasal drug delivery systems market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers of nasal drug delivery system, research and consulting firms, new entrants, and financial analysts
Various strategy matrices used in analyzing the nasal drug delivery systems market would provide stakeholders vital inputs to make strategic decisions accordingly
Detailed Segmentation:
Global Nasal Drug Delivery Systems Market, By Dosage Form:
Nasal Spray
Nasal Drops
Nasal Gels
Nasal Powders
Others
Global Nasal Drug Delivery Systems Market, By Container Type:
Non-pressurized Containers
Pressurized Containers
Global Nasal Drug Delivery Systems Market, By System Type:
Multi-dose
Bi-dose
Unit Dose
Global Nasal Drug Delivery Systems Market, By Therapeutic Application:
Allergic and Non-allergic Rhinitis
Nasal Congestion
Vaccination
Others
Global Nasal Drug Delivery Systems Market, By Distribution Channel:
Hospitals Pharmacies
Retail Pharmacies
Online Pharmacies
Global Nasal Drug Delivery Systems Market, By Region:
North America
By Dosage Form:
Nasal Spray
Nasal Drops
Nasal Gels
Nasal Powders
Others
By Container Type:
Non-pressurized Containers
Pressurized Containers
By System Type:
Multi-dose
Bi-dose
Unit Dose
By Therapeutic Application :
Allergic and Non-allergic Rhinitis
Nasal Congestion
Vaccination
Others
By Distribution Channel:
Hospitals Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
U.S.
Canada
Latin America
By Dosage Form:
Nasal Spray
Nasal Drops
Nasal Gels
Nasal Powders
Others
By Container Type:
Non-pressurized Containers
Pressurized Containers
By System Type:
Multi-dose
Bi-dose
Unit Dose
By Therapeutic Application :
Allergic and Non-allergic Rhinitis
Nasal Congestion
Vaccination
Others
By Distribution Channel:
Hospitals Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Dosage Form:
Nasal Spray
Nasal Drops
Nasal Gels
Nasal Powders
Others
By Container Type:
Non-pressurized Containers
Pressurized Containers
By System Type:
Multi-dose
Bi-dose
Unit Dose
By Therapeutic Application :
Allergic and Non-allergic Rhinitis
Nasal Congestion
Vaccination
Others
By Distribution Channel:
Hospitals Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
Germany
U.K.
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
By Dosage Form:
Nasal Spray
Nasal Drops
Nasal Gels
Nasal Powders
Others
By Container Type:
Non-pressurized Containers
Pressurized Containers
By System Type:
Multi-dose
Bi-dose
Unit Dose
By Therapeutic Application :
Allergic and Non-allergic Rhinitis
Nasal Congestion
Vaccination
Others
By Distribution Channel:
Hospitals Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
By Dosage Form:
Nasal Spray
Nasal Drops
Nasal Gels
Nasal Powders
Others
By Container Type:
Non-pressurized Containers
Pressurized Containers
By System Type:
Multi-dose
Bi-dose
Unit Dose
By Therapeutic Application :
Allergic and Non-allergic Rhinitis
Nasal Congestion
Vaccination
Others
By Distribution Channel:
Hospitals Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
GCC
Israel
Rest of Middle East
Africa
By Dosage Form:
Nasal Spray
Nasal Drops
Nasal Gels
Nasal Powders
Others
By Container Type:
Non-pressurized Containers
Pressurized Containers
By System Type:
Multi-dose
Bi-dose
Unit Dose
By Therapeutic Application :
Allergic and Non-allergic Rhinitis
Nasal Congestion
Vaccination
Others
By Distribution Channel:
Hospitals Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
North Africa
Central Africa
South Africa
Company Profiles
Merck & Co.*
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Market Strategies
GlaxoSmithKline plc
AstraZeneca plc
Johnson & Johnson
Pfizer Inc.
Baxter International, Inc.
Valeant Pharmaceuticals International, Inc.
Becton, Dickinson and Company
Novartis AG
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Overview
o Report Description
o Market Definition and Scope
o Executive Summary
o Market Snippet, By Dosage Form
o Market Snippet, By Container Type
o Market Snippet, By System Type
o Market Snippet, By Therapeutic Application
o Market Snippet, By Distribution Channel
o Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Drivers
o Restraints
o Market Opportunities
o Impact Analysis
o Industry Trends
o Recent Approvals
o Regulatory Scenario
o Epidemiology
o PEST Analysis
4. Global Nasal Drug Delivery Systems Market, By Dosage Form, 2016 - 2026, (US$ Million)
o Introduction
o Market Share Analysis, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, 2017 - 2026
o Segment Trends
o Nasal Spray
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Nasal Drops
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Nasal Gels
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Nasal Powders
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Others
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
5. Global Nasal Drug Delivery Systems Market, By Container Type, 2016-2026, (US$ Million)
o Introduction
o Market Share Analysis, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, 2017 - 2026
o Segment Trends
o Non-Pressurized Containers
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Pressurized Containers
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
6. Global Nasal Drug Delivery Systems Market, By System Type, 2016-2026, (US$ Million)
o Introduction
o Market Share Analysis, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, 2017 - 2026
o Segment Trends
o Multi Dose
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Bi-Dose
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Unit Dose
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
7. Global Nasal Drug Delivery Systems Market, By Therapeutic Application, 2016-2026, (US$ Million)
o Introduction
o Market Share Analysis, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, 2017 - 2026
o Segment Trends
o Allergic and Non-Allergic Rhinitis
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Nasal Congestion
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Vaccination
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Others
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
8. Global Nasal Drug Delivery Systems Market, By Distribution Channel, 2016-2026, (US$ Million)
o Introduction
o Market Share Analysis, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, 2017 - 2026
o Segment Trends
o Hospitals Pharmacies
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Retail Pharmacies
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Online Pharmacies
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
9. Global Nasal Drug Delivery Systems Market, By Regions, 2016-2026, (US$ Million)
o Introduction
o Market Share Analysis, By Region, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, By Region, 2017 - 2026
o Regional Trends
o North America
o Market Size and Forecast, By Dosage Form, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Container Type, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By System Type, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Therapeutic Application, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
• U.S.
• Canada
o Europe
o Market Size and Forecast, By Dosage Form, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Container Type, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By System Type, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Therapeutic Application, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
o Asia Pacific
o Market Size and Forecast, By Dosage Form, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Container Type, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By System Type, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Therapeutic Application, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
• China
• Japan
• India
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
o Latin America
o Market Size and Forecast, By Dosage Form, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Container Type, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By System Type, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Therapeutic Application, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
o Middle East
o Market Size and Forecast, By Dosage Form, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Container Type, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By System Type, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Therapeutic Application, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
• GCC Countries
• Israel
• Rest of Middle East
o Africa
o Market Size and Forecast, By Dosage Form, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Container Type, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By System Type, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Therapeutic Application, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
• Northern Africa
• Central Africa
• South Africa
10. Competitive Landscape
o Heat Map Analysis
o Company Profiles
o Merck & Co.*
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Market Strategies
o GlaxoSmithKline plc
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Market Strategies
o AstraZeneca plc
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Market Strategies
o Johnson & Johnson
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Market Strategies
o Pfizer Inc.
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Market Strategies
o Baxter International, Inc.
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Market Strategies
o Valeant Pharmaceuticals International, Inc.
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Market Strategies
o Becton, Dickinson and Company
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Market Strategies
o Novartis AG
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Market Strategies
11. Analyst Views
12. Section
o References
o Research Methodology
o About Us and Sales Contact
*Browse 40 market data tables and 38 figures on "Nasal Drug Delivery Systems Market - Global forecast to 2026".
Request Discount 
Inquire Before Buy
